Molecular diagnostics in gastric cancer

Frontiers in Bioscience - Landmark

Volumn 19, Issue 2, 2014, Pages 312-338

  Bornschein, Jan ^a,b   Leja, Marcis ^c   Kupcinskas, Juozas ^d   Link, Alexander ^a   Weaver, Jamie ^b   Rugge, Massimo ^e   Malfertheiner, Peter ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b HUTCHISON MRC RESEARCH CENTRE   (United Kingdom)

^c UNIVERSITY OF LATVIA   (Latvia)

^d LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^e UNIVERSITY OF PADOVA   (Italy)

Author keywords

Array comparative genomic hybridisation; Endoscopic imaging; Gastric cancer; Her2; MiRNA; Mucins; Pepsinogens; Review

Indexed keywords

GENETICS; HUMAN; MOLECULAR DIAGNOSIS; PATHOLOGY; REVIEW; STOMACH TUMOR;

HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; STOMACH NEOPLASMS;

EID: 84903852453     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4210     Document Type: Review

References (290)

1. D M Parkin: The global health burden of infection-associated cancers in the year 2002. International Journal of Cancer, 118(12), 3030-3044 (2006)
2. A Jemal, F Bray, M M Center, J Ferlay, E Ward and D Forman: Global cancer statistics. CA: A Cancer Journal for Clinicians, 61(2), 69-90 (2011)
3. S J Crane, G R Locke, 3r, W S Harmsen, N N Diehl, A R Zinsmeister, L J Melton, Y Romero and N J Talley: The changing incidence of oesophageal and gastric adenocarcinoma by anatomic sub-site. Aliment Pharmacol Ther, 25(4), 447-53 (2007)
4. W J Blot and J K McLaughlin: The changing epidemiology of esophageal cancer. Semin Oncol, 26(5 Suppl 15), 2-8 (1999)
5. S S Devesa, W J Blot and J F Fraumeni: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer, 83(10), 2049-53 (1998)
6. A A Botterweck, L J Schouten, A Volovics, E Dorant and P A van Den Brandt: Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol, 29(4), 645-54 (2000)
7. N Schmidt, U Peitz, H Lippert and P Malfertheiner: Missing gastric cancer in dyspepsia. Aliment Pharmacol Ther, 21(7), 813-20 (2005)
8. U Peitz and P Malfertheiner: Chromoendoscopy: from a research tool to clinical progress. Dig Dis, 20(2), 111-9 (2002)
9. G Tao, L Xing-Hua, Y Ai-Ming, Z Wei-Xun, Y Fang, W Xi, W Li-Yin, L Chong-Mei, F Gui-Jun, S Hui-Jun, W Dong-Sheng, L Yue, L Xiao-Qing and Q Jia-Ming: Enhanced magnifying endoscopy for differential diagnosis of superficial gastric lesions identified with white-light endoscopy. Gastric Cancer (2013)
10. N Uedo, M Fujishiro, K Goda, D Hirasawa, Y Kawahara, J H Lee, R Miyahara, Y Morita, R Singh, M Takeuchi, S Wang and T Yao: Role of narrow band imaging for diagnosis of early-stage esophagogastric cancer: current consensus of experienced endoscopists in Asia-Pacific region. Dig Endosc, 23 Suppl 1, 58-71 (2011)
11. M Kato, M Kaise, J Yonezawa, H Toyoizumi, N Yoshimura, Y Yoshida, M Kawamura and H Tajiri: Magnifying endoscopy with narrow-band imaging achieves superior accuracy in the differential diagnosis of superficial gastric lesions identified with white-light endoscopy: a prospective study. Gastrointest Endosc, 72(3), 523-9 (2010)
12. Y Ezoe, M Muto, N Uedo, H Doyama, K Yao, I Oda, K Kaneko, Y Kawahara, C Yokoi, Y Sugiura, H Ishikawa, Y Takeuchi, Y Kaneko and Y Saito: Magnifying narrowband imaging is more accurate than conventional white-light imaging in diagnosis of gastric mucosal cancer. Gastroenterology, 141(6), 2017-2025 e3 (2011)
13. J Zhang, S B Guo and Z J Duan: Application of magnifying narrow-band imaging endoscopy for diagnosis of early gastric cancer and precancerous lesion. BMC Gastroenterol, 11, 135 (2011)
14. S Maki, K Yao, T Nagahama, T Beppu, T Hisabe, Y Takaki, F Hirai, T Matsui, H Tanabe and A Iwashita: Magnifying endoscopy with narrow-band imaging is useful in the differential diagnosis between low-grade adenoma and early cancer of superficial elevated gastric lesions. Gastric Cancer (2012)
15. M Nakamura, T Shibata, T Tahara, D Yoshioka, M Okubo, Y Mizoguchi, M Kuroda, T Arisawa and I Hirata: The usefulness of magnifying endoscopy with narrow-band imaging to distinguish carcinoma in flat elevated lesions in the stomach diagnosed as adenoma by using biopsy samples. Gastrointest Endosc, 71(6), 1070-5 (2010)
16. K Miwa, H Doyama, R Ito, H Nakanishi, K Hirano, S Inagaki, K Tominaga, N Yoshida, K Takemura, S Yamada, Y Kaneko, K Katayanagi, H Kurumaya, T Okada and M Yamagishi: Can magnifying endoscopy with narrow band imaging be useful for low grade adenomas in preoperative biopsy specimens? Gastric Cancer, 15(2), 170-8 (2012)
17. R Kosaka, K Tanaka, S Tano, R Takayama, K Nishikawa, Y Hamada, H Toyoda, K Ninomiya, M Katsurahara, H Inoue, N Horiki, N Katayama and Y Takei: Magnifying endoscopy for diagnosis of residual/local recurrent gastric neoplasms after previous endoscopic treatment. Surg Endosc, 26(8), 2299-305 (2012)
18. H Y Li, J Dai, H B Xue, Y J Zhao, X Y Chen, Y J Gao, Y Song, Z Z Ge and X B Li: Application of magnifying endoscopy with narrow-band imaging in diagnosing gastric lesions: a prospective study. Gastrointest Endosc, 76(6), 1124-32 (2012)
19. H Kobara, H Mori, S Fujihara, M Kobayashi, N Nishiyama, T Nomura, K Kato, S Ishihara, T Morito, K Mizobuchi, H Iwama and T Masaki: Prediction of invasion depth for submucosal differentiated gastric cancer by magnifying endoscopy with narrow-band imaging. Oncol Rep, 28(3), 841-7 (2012)
20. A Yokoyama, H Inoue, H Minami, Y Wada, Y Sato, H Satodate, S Hamatani and S E Kudo: Novel narrow-band imaging magnifying endoscopic classification for early gastric cancer. Dig Liver Dis, 42(10), 704-8 (2010)
21. P Pimentel-Nunes, M Dinis-Ribeiro, J B Soares, R Marcos-Pinto, C Santos, C Rolanda, R P Bastos, M Areia, L Afonso, J Bergman, P Sharma, T Gotoda, R Henrique and L Moreira-Dias: A multicenter validation of an endoscopic classification with narrow band imaging for gastric precancerous and cancerous lesions. Endoscopy, 44(3), 236-46 (2012)
22. M Kaise, M Kato, M Urashima, Y Arai, H Kaneyama, Y Kanzazawa, J Yonezawa, Y Yoshida, N Yoshimura, T Yamasaki, K Goda, H Imazu, H Arakawa, K Mochizuki and H Tajiri: Magnifying endoscopy combined with narrow-band imaging for differential diagnosis of superficial depressed gastric lesions. Endoscopy, 41(4), 310-5 (2009)
23. Y Tsuji, K Ohata, M Sekiguchi, A Ohno, T Ito, H Chiba, T Gunji, J Fukushima, N Yamamichi, M Fujishiro, N Matsuhashi and K Koike: Magnifying endoscopy with narrow-band imaging helps determine the management of gastric adenomas. Gastric Cancer, 15(4), 414-8 (2012)
24. K Yao: How is the VS (vessel plus surface) classification system applicable to magnifying narrow-band imaging examinations of gastric neoplasias initially diagnosed as low-grade adenomas? Gastric Cancer, 15(2), 118-20 (2012)
25. K Yao, G K Anagnostopoulos and K Ragunath: Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy, 41(5), 462-7 (2009)
26. M Kobayashi, H Tajiri, E Seike, M Shitaya, S Tounou, M Mine and K Oba: Detection of early gastric cancer by a real-time autofluorescence imaging system. Cancer Lett, 165(2), 155-9 (2001)
27. J Haringsma, G N Tytgat, H Yano, H Iishi, M Tatsuta, T Ogihara, H Watanabe, N Sato, N Marcon, B C Wilson and R W Cline: Autofluorescence endoscopy: feasibility of detection of GI neoplasms unapparent to white light endoscopy with an evolving technology. Gastrointest Endosc, 53(6), 642-50 (2001)
28. N Uedo, H Iishi, M Tatsuta, T Yamada, H Ogiyama, K Imanaka, N Sugimoto, K Higashino, R Ishihara, H Narahara and S Ishiguro: A novel videoendoscopy system by using autofluorescence and reflectance imaging for diagnosis of esophagogastric cancers. Gastrointest Endosc, 62(4), 521-8 (2005)
29. M Kato, M Kaise, J Yonezawa, Y Yoshida and H Tajiri: Autofluorescence endoscopy versus conventional white light endoscopy for the detection of superficial gastric neoplasia: a prospective comparative study. Endoscopy, 39(11), 937-41 (2007)
30. M Kato, M Kaise, J Yonezawa, K Goda, H Toyoizumi, N Yoshimura, Y Yoshida, M Kawamura and H Tajiri: Trimodal imaging endoscopy may improve diagnostic accuracy of early gastric neoplasia: a feasibility study. Gastrointest Endosc, 70(5), 899-906 (2009)
31. W L Curvers, F G van Vilsteren, L C Baak, C Bohmer, R C Mallant-Hent, A H Naber, A van Oijen, C Y Ponsioen, P Scholten, E Schenk, E Schoon, C A Seldenrijk, G A Meijer, F J ten Kate and J J Bergman: Endoscopic trimodal imaging versus standard video endoscopy for detection of early Barrett's neoplasia: a multicenter, randomized, crossover study in general practice. Gastrointest Endosc, 73(2), 195-203 (2011)
32. D F Boerwinkel, M Di Pietro, X Liu, M K Shariff, P Lao-Sirieix, C E Walker, M Visser, M O'Donovan, P Kaye, J J Bergman and R C Fitzgerald: Endoscopic TriModal imaging and biomarkers for neoplasia conjoined: a feasibility study in Barrett's esophagus. Dis Esophagus (2012)
33. S W Jung, K S Lim, J U Lim, J W Jeon, H P Shin, S H Kim, E K Lee, J J Park, J M Cha, K R Joo and J I Lee: Flexible spectral imaging color enhancement (FICE) is useful to discriminate among non-neoplastic lesion, adenoma, and cancer of stomach. Dig Dis Sci, 56(10), 2879-86 (2011)
34. H Osawa, H Yamamoto, Y Miura, M Yoshizawa, K Sunada, K Satoh and K Sugano: Diagnosis of extent of early gastric cancer using flexible spectral imaging color enhancement. World J Gastrointest Endosc, 4(8), 356-61 (2012)
35. H Osawa, H Yamamoto, Y Miura, H Ajibe, H Shinhata, M Yoshizawa, K Sunada, S Toma, K Satoh and K Sugano: Diagnosis of depressed-type early gastric cancer using small-caliber endoscopy with flexible spectral imaging color enhancement. Dig Endosc, 24(4), 231-6 (2012)
36. J N Zhang, Y Q Li, Y A Zhao, T Yu, J P Zhang, Y T Guo and H Liu: Classification of gastric pit patterns by confocal endomicroscopy. Gastrointest Endosc, 67(6), 843- 53 (2008)
37. Y T Guo, Y Q Li, T Yu, T G Zhang, J N Zhang, H Liu, F G Liu, X J Xie, Q Zhu and Y A Zhao: Diagnosis of gastric intestinal metaplasia with confocal laser endomicroscopy in vivo: a prospective study. Endoscopy, 40(7), 547-53 (2008)
38. K Banno, Y Niwa, R Miyahara, M Nakamura, T Nagaya, T Nagasaka, O Watanabe, T Ando, H Kawashima, N Ohmiya, A Itoh, Y Hirooka and H Goto: Confocal endomicroscopy for phenotypic diagnosis of gastric cancer. J Gastroenterol Hepatol, 25(4), 712-8 (2010)
39. R Ji, X L Zuo, T Yu, X M Gu, Z Li, C J Zhou and Y Q Li: Mucosal barrier defects in gastric intestinal metaplasia: in vivo evaluation by confocal endomicroscopy. Gastrointest Endosc, 75(5), 980-7 (2012)
40. L G Lim, K G Yeoh, M Salto-Tellez, C J Khor, M Teh, Y H Chan, J B So, A Rajnakova, E Shen, S Srivastava and K Y Ho: Experienced versus inexperienced confocal endoscopists in the diagnosis of gastric adenocarcinoma and intestinal metaplasia on confocal images. Gastrointest Endosc, 73(6), 1141-7 (2011)
41. W B Li, X L Zuo, C Q Li, F Zuo, X M Gu, T Yu, C L Chu, T G Zhang and Y Q Li: Diagnostic value of confocal laser endomicroscopy for gastric superficial cancerous lesions. Gut, 60(3), 299-306 (2011)
42. Z Li, T Yu, X L Zuo, X M Gu, C J Zhou, R Ji, C Q Li, P Wang, T G Zhang, K Y Ho and Y Q Li: Confocal laser endomicroscopy for in vivo diagnosis of gastric intraepithelial neoplasia: a feasibility study. Gastrointest Endosc, 72(6), 1146-53 (2010)
43. S R Jeon, W Y Cho, S Y Jin, Y K Cheon, S R Choi and J Y Cho: Optical biopsies by confocal endomicroscopy prevent additive endoscopic biopsies before endoscopic submucosal dissection in gastric epithelial neoplasias: a prospective, comparative study. Gastrointest Endosc, 74(4), 772-80 (2011)
44. R Ji, X L Zuo, C Q Li, C J Zhou and Y Q Li: Confocal endomicroscopy for in vivo prediction of completeness after endoscopic mucosal resection. Surg Endosc, 25(6), 1933-8 (2011)
45. Z Li, X L Zuo, C Q Li, C J Zhou, J Liu, M Goetz, R Kiesslich, K C Wu, D M Fan and Y Q Li: In vivo molecular imaging of gastric cancer by targeting MG7 antigen with confocal laser endomicroscopy. Endoscopy, 45(2), 79-85 (2013)
46. E Savarino, M Corbo, P Dulbecco, L Gemignani, E Giambruno, L Mastracci, F Grillo and V Savarino: Narrowband imaging with magnifying endoscopy is accurate for detecting gastric intestinal metaplasia. World J Gastroenterol, 19(17), 2668-75 (2013)
47. N Uedo, R Ishihara, H Iishi, S Yamamoto, T Yamada, K Imanaka, Y Takeuchi, K Higashino, S Ishiguro and M Tatsuta: A new method of diagnosing gastric intestinal metaplasia: narrow-band imaging with magnifying endoscopy. Endoscopy, 38(8), 819-24 (2006)
48. R Pittayanon, R Rerknimitr, N Wisedopas, W Ridtitid, P Kongkam, S Treeprasertsuk, P Angsuwatcharakon, V Mahachai and P Kullavanijaya: Flexible spectral imaging color enhancement plus probe-based confocal laser endomicroscopy for gastric intestinal metaplasia detection. J Gastroenterol Hepatol, 28(6), 1004-9 (2013)
49. M Dinis-Ribeiro, M Areia, A C de Vries, R Marcos-Pinto, M Monteiro-Soares, A O'Connor, C Pereira, P Pimentel-Nunes, R Correia, A Ensari, J M Dumonceau, J C Machado, G Macedo, P Malfertheiner, T Matysiak-Budnik, F Megraud, K Miki, C O'Morain, R M Peek, T Ponchon, A Ristimaki, B Rembacken, F Carneiro and E J Kuipers: Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy, 44(1), 74-94 (2012)
50. E Xirouchakis, F Laoudi, L Tsartsali, C Spiliadi and S D Georgopoulos: Screening for gastric premalignant lesions with narrow band imaging, white light and updated Sydney protocol or both? Dig Dis Sci, 58(4), 1084-90 (2013)
51. M F Dixon, R M Genta, J H Yardley and P Correa: Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol, 20(10), 1161-81 (1996)
52. M Rugge and R M Genta: Staging and grading of chronic gastritis. Hum Pathol, 36(3), 228-33 (2005)
53. M Rugge, M de Boni, G Pennelli, M de Bona, L Giacomelli, M Fassan, D Basso, M Plebani and D Y Graham: Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Alimentary pharmacology & therapeutics, 31(10), 1104-11 (2010)
54. I Daugule, A Sudraba, H M Chiu, K Funka, A Ivanauskas, D Janciauskas, L Jonaitis, G Kiudelis, I Tolmanis, A Vanags, J T Lin, L Kupcinskas and M Leja: Gastric plasma biomarkers and Operative Link for Gastritis Assessment gastritis stage. European journal of gastroenterology & hepatology, 23(4), 302-7 (2011)
55. L G Capelle, A C de Vries, J Haringsma, F Ter Borg, R A de Vries, M J Bruno, H van Dekken, J Meijer, N C van Grieken and E J Kuipers: The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc, 71(7), 1150-8 (2010)
56. M Rugge, M Fassan, M Pizzi, F Farinati, G C Sturniolo, M Plebani and D Y Graham: Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment. World J Gastroenterol, 17(41), 4596-601 (2011)
57. C M den Hoed, I L Holster, L G Capelle, A C de Vries, B den Hartog, F Ter Borg, K Biermann and E J Kuipers: Follow-up of premalignant lesions in patients at risk for progression to gastric cancer. Endoscopy, 45(4), 249-56 (2013)
58. M Fassan, M Pizzi, F Farinati, D Nitti, V Zagonel, R M Genta and M Rugge: Lesions indefinite for intraepithelial neoplasia and OLGA staging for gastric atrophy. Am J Clin Pathol, 137(5), 727-32 (2012)
59. M Rugge, M Fassan, M Pizzi, V Zorzetto, G Maddalo, S Realdon, M De Bernard, C Betterle, R Cappellesso, G Pennelli, M de Boni and F Farinati: Autoimmune gastritis: histology phenotype and OLGA staging. Aliment Pharmacol Ther, 35(12), 1460-6 (2012)
60. W Hoffmann: Stem Cells, Self-renewal and Cancer of the Gastric Epithelium. Curr Med Chem 19(35), 5975-83 (2012)
61. S Nomura, T Baxter, H Yamaguchi, C Leys, A B Vartapetian, J G Fox, J R Lee, T C Wang and J R Goldenring: Spasmolytic polypeptide expressing metaplasia to preneoplasia in H. felis-infected mice. Gastroenterology, 127(2), 582-94 (2004)
62. Y C Tsai, W H Hsiao, H B Yang, H C Cheng, W L Chang, C C Lu and B S Sheu: The corpus-predominant gastritis index may serve as an early marker of Helicobacter pylori-infected patients at risk of gastric cancer. Aliment Pharmacol Ther, 37(10), 969-78 (2013)
63. A M Halldorsdottir, M Sigurdardottrir, J G Jonasson, M Oddsdottir, J Magnusson, J R Lee and J R Goldenring: Spasmolytic polypeptide-expressing metaplasia (SPEM) associated with gastric cancer in Iceland. Dig Dis Sci, 48(3), 431-41 (2003)
64. H Yamaguchi, J R Goldenring, M Kaminishi and J R Lee: Identification of spasmolytic polypeptide expressing metaplasia (SPEM) in remnant gastric cancer and surveillance postgastrectomy biopsies. Dig Dis Sci, 47(3), 573-8 (2002)
65. K Nozaki, M Ogawa, J A Williams, B J Lafleur, V Ng, R I Drapkin, J C Mills, S F Konieczny, S Nomura and J R Goldenring: A molecular signature of gastric metaplasia arising in response to acute parietal cell loss. Gastroenterology, 134(2), 511-22 (2008)
66. K T Nam, R L O'Neal, R J Coffey, P E Finke, N Barker and J R Goldenring: Spasmolytic polypeptide-expressing metaplasia (SPEM) in the gastric oxyntic mucosa does not arise from Lgr5-expressing cells. Gut (2011)
67. T Uehara, D Ma, Y Yao, J P Lynch, K Morales, A Ziober, M Feldman, H Ota and A R Sepulveda: H. pylori infection is associated with DNA damage of Lgr5-positive epithelial stem cells in the stomach of patients with gastric cancer. Dig Dis Sci, 58(1), 140-9 (2013)
68. H Oshima and M Oshima: Mouse models of gastric tumors: Wnt activation and PGE2 induction. Pathol Int, 60(9), 599-607 (2010)
69. S D Babu, V Jayanthi, N Devaraj, C A Reis and H Devaraj: Expression profile of mucins (MUC2, MUC5AC and MUC6) in Helicobacter pylori infected pre-neoplastic and neoplastic human gastric epithelium. Mol Cancer, 5, 10 (2006)
70. T Tsukamoto, K Inada, H Tanaka, T Mizoshita, M Mihara, T Ushijima, Y Yamamura, S Nakamura and M Tatematsu: Down-regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: inverse correlation during progression from gastric/intestinal-mixed to complete intestinal metaplasia. J Cancer Res Clin Oncol, 130(3), 135-45 (2004)
71. H S Kim, J S Lee, J N Freund, K W Min, W Kim, S W Juhng and C S Park: CDX-2 homeobox gene expression in human gastric carcinoma and precursor lesions. J Gastroenterol Hepatol, 21(2), 438-42 (2006)
72. R Mejias-Luque, S K Linden, M Garrido, H Tye, M Najdovska, B J Jenkins, M Iglesias, M Ernst and C de Bolos: Inflammation modulates the expression of the intestinal mucins MUC2 and MUC4 in gastric tumors. Oncogene, 29(12), 1753-62 (2010)
73. H M Kang, N Kim, Y S Park, J H Hwang, J W Kim, S H Jeong, D H Lee, H S Lee, H C Jung and I S Song: Effects of Helicobacter pylori Infection on gastric mucin expression. J Clin Gastroenterol, 42(1), 29-35 (2008)
74. R Q Wang and D C Fang: Effects of Helicobacter pylori infection on mucin expression in gastric carcinoma and pericancerous tissues. J Gastroenterol Hepatol, 21(2), 425-31 (2006)
75. H Shiroshita, H Watanabe, Y Ajioka, G Watanabe, K Nishikura and S Kitano: Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains. Pathol Int, 54(5), 311-21 (2004)
76. K Wakatsuki, Y Yamada, M Narikiyo, M Ueno, T Takayama, H Tamaki, K Miki, S Matsumoto, K Enomoto, T Yokotani and Y Nakajima: Clinicopathological and prognostic significance of mucin phenotype in gastric cancer. J Surg Oncol, 98(2), 124-9 (2008)
77. K Yamamoto, M Kato, M Takahashi, M Haneda, K Shinada, U Nishida, T Yoshida, N Sonoda, S Ono, M Nakagawa, Y Mori, S Nakagawa, K Mabe, Y Shimizu, J Moriya, K Kubota, Y Matsuno, T Shimoda, H Watanabe and M Asaka: Clinicopathological analysis of early-stage gastric cancers detected after successful eradication of Helicobacter pylori. Helicobacter, 16(3), 210-6 (2011)
78. S E Baldus, S P Monig, V Arkenau, F G Hanisch, P M Schneider, J Thiele, A H Holscher and H P Dienes: Correlation of MUC5AC immunoreactivity with histopathological subtypes and prognosis of gastric carcinoma. Ann Surg Oncol, 9(9), 887-93 (2002)
79. T Shimamura, H Ito, J Shibahara, A Watanabe, Y Hippo, H Taniguchi, Y Chen, T Kashima, T Ohtomo, F Tanioka, H Iwanari, T Kodama, T Kazui, H Sugimura, M Fukayama and H Aburatani: Overexpression of MUC13 is associated with intestinal-type gastric cancer. Cancer Sci, 96(5), 265-73 (2005)
80. D M Maher, B K Gupta, S Nagata, M Jaggi and S C Chauhan: Mucin 13: structure, function, and potential roles in cancer pathogenesis. Mol Cancer Res, 9(5), 531-7 (2011)
81. V Barresi, E Vitarelli, M Grosso, G Tuccari and G Barresi: Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas. Eur J Histochem, 50(4), 301-9 (2006)
82. O Ilhan, U Han, B Onal and S Y Celik: Prognostic significance of MUC1, MUC2 and MUC5AC expressions in gastric carcinoma. Turk J Gastroenterol, 21(4), 345-52 (2010)
83. H S Han, S Y Lee, K Y Lee, S N Hong, J H Kim, I K Sung, H S Park, C J Jin and Y I Min: Unclassified mucin phenotype of gastric adenocarcinoma exhibits the highest invasiveness. J Gastroenterol Hepatol, 24(4), 658-66 (2009)
84. O J Lee, H J Kim, J R Kim and H Watanabe: The prognostic significance of the mucin phenotype of gastric adenocarcinoma and its relationship with histologic classifications. Oncol Rep, 21(2), 387-93 (2009)
85. L Xue, X Zhang, Y Li, H Yang, X Li, J Mi, H Wang, J Wang and X Yan: Differences of immunophenotypic markers and signaling molecules between adenocarcinomas of gastric cardia and distal stomach. Hum Pathol, 42(4), 594-601 (2011)
86. F Oz Puyan, N Can, F Ozyilmaz, U Usta, N Sut, E Tastekin and S Altaner: The relationship among PDX1, CDX2, and mucin profiles in gastric carcinomas; correlations with clinicopathologic parameters. J Cancer Res Clin Oncol, 137(12), 1749-62 (2011)
87. Y Tajima, K Yamazaki, R Makino, N Nishino, S Aoki, M Kato, K Morohara, T Kaetsu and M Kusano: Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background. Clin Cancer Res, 12(21), 6469-79 (2006)
88. M F Retterspitz, S P Monig, S Schreckenberg, P M Schneider, A H Holscher, H P Dienes and S E Baldus: Expression of beta-catenin, MUC1 and c-met in diffuse-type gastric carcinomas: correlations with tumour progression and prognosis. Anticancer Res, 30(11), 4635-41 (2010)
89. B Kocer, A Soran, G Kiyak, S Erdogan, A Eroglu, B Bozkurt, C Solak and O Cengiz: Prognostic significance of mucin expression in gastric carcinoma. Dig Dis Sci, 49(6), 954-64 (2004)
90. N Saeki, A Saito, I J Choi, K Matsuo, S Ohnami, H Totsuka, S Chiku, A Kuchiba, Y S Lee, K A Yoon, M C Kook, S R Park, Y W Kim, H Tanaka, K Tajima, H Hirose, F Tanioka, Y Matsuno, H Sugimura, S Kato, T Nakamura, T Nishina, W Yasui, K Aoyagi, H Sasaki, K Yanagihara, H Katai, T Shimoda, T Yoshida, Y Nakamura, S Hirohashi and H Sakamoto: A functional single nucleotide polymorphism in mucin 1, at chromosome 1q22, determines susceptibility to diffuse-type gastric cancer. Gastroenterology, 140(3), 892-902 (2011)
91. Y. Jia, C. Persson, L. Hou, Z. Zheng, M. Yeager, J. Lissowska, S. J. Chanock, W. H. Chow and W. Ye: A comprehensive analysis of common genetic variation in MUC1, MUC5AC, MUC6 genes and risk of stomach cancer. Cancer Causes Control, 21(2), 313-21 (2010)
92. F Marin, C Bonet, X Munoz, N Garcia, M L Pardo, J M Ruiz-Liso, P Alonso, G Capella, J M Sanz-Anquela, C A Gonzalez and N Sala: Genetic variation in MUC1, MUC2 and MUC6 genes and evolution of gastric cancer precursor lesions in a long-term follow-up in a high-risk area in Spain. Carcinogenesis, 33(5), 1072-80 (2012)
93. P Mesquita, A J Peixoto, R Seruca, C Hanski, R Almeida, F Silva, C Reis and L David: Role of site-specific promoter hypomethylation in aberrant MUC2 mucin expression in mucinous gastric carcinomas. Cancer Lett, 189(2), 129-36 (2003)
94. L Dardaei, R Shahsavani, A Ghavamzadeh, M Behmanesh, E Aslankoohi, K Alimoghaddam and S H Ghaffari: The detection of disseminated tumor cells in bone marrow and peripheral blood of gastric cancer patients by multimarker (CEA, CK20, TFF1 and MUC2) quantitative real-time PCR. Clin Biochem, 44(4), 325-30 (2011)
95. K Klaamas, O Kurtenkov, S von Mensdorff-Pouilly, L Shljapnikova, L Miljukhina, V Brjalin and A Lipping: Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer. Immunol Invest, 36(4), 371-86 (2007)
96. M Kim, H J Kim, B Y Choi, J H Kim, K S Song, S M Noh, J C Kim, D S Han, S Y Kim and Y S Kim: Identification of potential serum biomarkers for gastric cancer by a novel computational method, multiple normal tissues corrected differential analysis. Clin Chim Acta, 413(3-4), 428-33 (2012)
97. Y J Bang, E Van Cutsem, A Feyereislova, H C Chung, L Shen, A Sawaki, F Lordick, A Ohtsu, Y Omuro, T Satoh, G Aprile, E Kulikov, J Hill, M Lehle, J Ruschoff and Y K Kang: Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet, 376(9742), 687-97 (2010)
98. Y Kataoka, H Okabe, A Yoshizawa, S Minamiguchi, K Yoshimura, H Haga and Y Sakai: HER2 expression and its clinicopathological features in resectable gastric cancer. Gastric Cancer (2012)
99. C Gomez-Martin, E Garralda, M J Echarri, A Ballesteros, A Arcediano, J L Rodriguez-Peralto, M Hidalgo and F Lopez-Rios: HER2/neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer. J Clin Pathol, 65(8), 751-7 (2012)
100. K R Jones, S Jang, J Y Chang, J Kim, I S Chung, C H Olsen, D S Merrell and J H Cha: Polymorphisms in the intermediate region of VacA impact Helicobacter pylori-induced disease development. J Clin Microbiol, 49(1), 101-10 (2011)
101. Y Y Janjigian, D Werner, C Pauligk, K Steinmetz, D P Kelsen, E Jager, H M Altmannsberger, E Robinson, L J Tafe, L H Tang, M A Shah and S E Al-Batran: Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis. Ann Oncol, 23(10), 2656-62 (2012)
102. T C Chua and N D Merrett: Clinicopathologic factors associated with HER2-positive gastric cancer and its impact on survival outcomes - a systematic review. Int J Cancer, 130(12), 2845-56 (2012)
103. B Yan, E X Yau, S S Bte Omar, C W Ong, B Pang, K G Yeoh and M Salto-Tellez: A study of HER2 gene amplification and protein expression in gastric cancer. J Clin Pathol, 63(9), 839-42 (2010)
104. A A Jacome, D R Wohnrath, C Scapulatempo Neto, E C Carneseca, S V Serrano, L S Viana, J S Nunes, E Z Martinez and J S Santos: Prognostic value of epidermal growth factor receptors in gastric cancer: a survival analysis by Weibull model incorporating long-term survivors. Gastric Cancer (2013)
105. M Terashima, K Kitada, A Ochiai, W Ichikawa, I Kurahashi, S Sakuramoto, H Katai, T Sano, H Imamura and M Sasako: Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer. Clin Cancer Res, 18(21), 5992-6000 (2012)
106. K Shitara, Y Yatabe, K Matsuo, M Sugano, C Kondo, D Takahari, T Ura, M Tajika, S Ito and K Muro: Prognosis of patients with advanced gastric cancer by HER2 status and trastuzumab treatment. Gastric Cancer (2012)
107. J T Jorgensen and M Hersom: HER2 as a Prognostic Marker in Gastric Cancer - A Systematic Analysis of Data from the Literature. J Cancer, 3, 137-44 (2012)
108. M Fassan, L Mastracci, F Grillo, V Zagonel, S Bruno, G Battaglia, F Pitto, D Nitti, T Celiento, G Zaninotto, R Fiocca and M Rugge: Early HER2 dysregulation in gastric and oesophageal carcinogenesis. Histopathology, 61(5), 769-776 (2012)
109. C Bozzetti, F V Negri, C A Lagrasta, P Crafa, C Bassano, I Tamagnini, G Gardini, R Nizzoli, F Leonardi, D Gasparro, R Camisa, S Cavalli, E M Silini and A Ardizzoni: Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma. Br J Cancer, 104(9), 1372-6 (2011)
110. F Pagni, S Zannella, S Ronchi, C Garanzini and B E Leone: HER2 Status of Gastric Carcinoma and Corresponding Lymph Node Metastasis. Pathol Oncol Res (2012)
111. A F Okines, L C Thompson, D Cunningham, A Wotherspoon, J S Reis-Filho, R E Langley, T S Waddell, D Noor, Z Eltahir, R Wong and S Stenning: Effect of HER2 on prognosis and benefit from peri-operative chemotherapy in early oesophago-gastric adenocarcinoma in the MAGIC trial. Ann Oncol, 24(5), 1253-1261 (2013)
112. M Pirrelli, M L Caruso, M Di Maggio, R Armentano and A M Valentini: Are Biopsy Specimens Predictive of HER2 Status in Gastric Cancer Patients? Dig Dis Sci (2012)
113. V S Warneke, H M Behrens, C Boger, T Becker, F Lordick, M P Ebert and C Rocken: Her2/neu testing in gastric cancer: evaluating the risk of sampling errors. Ann Oncol, 24(3), 725-33 (2013)
114. N Fusco, E G Rocco, C Del Conte, C Pellegrini, G Bulfamante, F Di Nuovo, S Romagnoli and S Bosari: HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions. Mod Pathol (2013)
115. T Narita, A Seshimo, M Suzuki, J Murata and S Kameoka: Status of Tissue Expression and Serum Levels of HER2 in Gastric Cancer Patients in Japan. Hepatogastroenterology, 60(125) (2013)
116. F di Mario and L G Cavallaro: Non-invasive tests in gastric diseases. Dig Liver Dis, 40(7), 523-30 (2008)
117. K Borch, C K Axelsson, H Halgreen, M D Damkjaer Nielsen, T Ledin and P B Szesci: The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. Scand J Gastroenterol, 24(7), 870-6 (1989)
118. K Miki: Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer, 9(4), 245-53 (2006)
119. K Miki: Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method". Proc Jpn Acad Ser B Phys Biol Sci, 87(7), 405-14 (2011)
120. M Leja, L Kupcinskas, K Funka, A Sudraba, L Jonaitis, A Ivanauskas, D Janciauskas, G Kiudelis, H M Chiu and J T Lin: The validity of a biomarker method for indirect detection of gastric mucosal atrophy versus standard histopathology. Dig Dis Sci, 54(11), 2377-84 (2009)
121. Y Hattori, H Tashiro, T Kawamoto and Y Kodama: Sensitivity and specificity of mass screening for gastric cancer using the measurment of serum pepsinogens. Jpn J Cancer Res, 86(12), 1210-5 (1995)
122. S Kikuchi, M Kato, T Katsuyama, S Tominaga and M Asaka: Design and planned analyses of an ongoing randomized trial assessing the preventive effect of Helicobacter pylori eradication on occurrence of new gastric carcinomas after endoscopic resection. Helicobacter, 11(3), 147-51 (2006)
123. F Kitahara, K Kobayashi, T Sato, Y Kojima, T Araki and M A Fujino: Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut, 44(5), 693-7 (1999)
124. S Mizuno, M Kobayashi, S Tomita, I Miki, A Masuda, M Onoyama, Y Habu, H Inokuchi and Y Watanabe: Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. Gastric Cancer, 12(3), 158-63 (2009)
125. K Yanaoka, M Oka, C Mukoubayashi, N Yoshimura, S Enomoto, M Iguchi, H Magari, H Utsunomiya, H Tamai, K Arii, H Ohata, M Fujishiro, T Takeshita, O Mohara and M Ichinose: Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males. Cancer Epidemiol Biomarkers Prev, 17(4), 838-45 (2008)
126. J M Kang, N Kim, J Y Yoo, Y S Park, D H Lee, H Y Kim, H S Lee, G Choe, J S Kim, H C Jung and I S Song: The role of serum pepsinogen and gastrin test for the detection of gastric cancer in Korea. Helicobacter, 13(2), 146-56 (2008)
127. J Bornschein, M Selgrad, T Wex, D Kuester and P Malfertheiner: Serological assessment of gastric mucosal atrophy in gastric cancer. BMC Gastroenterol, 12, 10 (2012)
128. M S Kwak, N Kim, H S Lee, H E Lee, H C Jung and I S Song: Predictive power of serum pepsinogen tests for the development of gastric cancer in comparison to the histologic risk index. Dig Dis Sci, 55(8), 2275-82 (2010)
129. J Bornschein, M Selgrad, M Warnecke, D Kuester, T Wex and P Malfertheiner: H. pylori infection is a key risk factor for proximal gastric cancer. Dig Dis Sci, 55(11), 3124-31 (2010)
130. A Boussioutas, H Li, J Liu, P Waring, S Lade, A J Holloway, D Taupin, K Gorringe, I Haviv, P V Desmond and D D Bowtell: Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer. Cancer Res, 63(10), 2569-77 (2003)
131. P Sipponen, P Ranta, T Helske, I Kaariainen, T Maki, A Linnala, O Suovaniemi, A Alanko and M Harkonen: Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study. Scand J Gastroenterol, 37(7), 785-91 (2002)
132. H Vaananen, M Vauhkonen, T Helske, I Kaariainen, M Rasmussen, H Tunturi-Hihnala, J Koskenpato, M Sotka, M Turunen, R Sandstrom, M Ristikankare, A Jussila and P Sipponen: Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol, 15(8), 885-91 (2003)
133. L Agreus, E J Kuipers, L Kupcinskas, P Malfertheiner, F Di Mario, M Leja, V Mahachai, N Yaron, M van Oijen, G Perez Perez, M Rugge, J Ronkainen, M Salaspuro, P Sipponen, K Sugano and J Sung: Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol, 47(2), 136-47 (2012)
134. P Sipponen, M Harkonen, A Alanko and O Suovaniemi: Diagnosis of atrophic gastritis from a serum sample. Minerva Gastroenterol Dietol, 49(1), 11-21 (2003)
135. G Nardone, A Rocco, S Staibano, E Mezza, G Autiero, D Compare, G De Rosa and G Budillon: Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy. Aliment Pharmacol Ther, 22(11-12), 1139-46 (2005)
136. S Calatayud, A Alvarez and V M Victor: Gastrin: an acid-releasing, proliferative and immunomodulatory peptide? Mini Rev Med Chem, 10(1), 8-19 (2010)
137. P Sipponen, M Vauhkonen, T Helske, I Kaariainen and M Harkonen: Low circulating levels of gastrin-17 in patients with Barrett's esophagus. World J Gastroenterol, 11(38), 5988-92 (2005)
138. Y Abe, K Iijima, T Koike, K Asanuma, A Imatani, S Ohara and T Shimosegawa: Barrett's esophagus is characterized by the absence of Helicobacter pylori infection and high levels of serum pepsinogen I concentration in Japan. J Gastroenterol Hepatol, 24(1), 129-34 (2009)
139. M Leja, L Kupcinskas, K Funka, A Sudraba, L Jonaitis, A Ivanauskas, D Janciauskas, G Kuidelis, H M Chiu and J T Lin: Value of gastrin-17 in detecting antral atrophy. Adv Med Sci, 56(2), 145-50 (2011)
140. H Watabe, T Mitsushima, Y Yamaji, M Okamoto, R Wada, T Kokubo, H Doi, H Yoshida, T Kawabe and M Omata: Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut, 54(6), 764-8 (2005)
141. T Kudo, S Kakizaki, N Sohara, Y Onozato, S Okamura, Y Inui and M Mori: Analysis of ABC (D) stratification for screening patients with gastric cancer. World J Gastroenterol, 17(43), 4793-8 (2011)
142. K Miki, M Fujishiro, S Kodashima and N Yahagi: Long-term results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese population. Dig Endosc, 21(2), 78-81 (2009)
143. Y Oishi, Y Kiyohara, M Kubo, K Tanaka, Y Tanizaki, T Ninomiya, Y Doi, K Shikata, K Yonemoto, T Shirota, T Matsumoto and M Iida: The serum pepsinogen test as a predictor of gastric cancer: the Hisayama study. Am J Epidemiol, 163(7), 629-37 (2006)
144. K Yanaoka, M Oka, C Mukoubayashi, N Yoshimura, S Enomoto, M Iguchi, H Magari, H Utsunomiya, H Tamai, K Arii, H Ohata, M Fujishiro, T Takeshita, O Mohara and M Ichinose: Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 17(4), 838-45 (2008)
145. X Zhang, L Xue, L Xing, J Wang, J Cui, J Mi, X Xing, Z Du, J Misumi, Q Tian and L Wang: Low serum pepsinogen I and pepsinogen I/II ratio and Helicobacter pylori infection are associated with increased risk of gastric cancer: 14-year follow up result in a rural Chinese community. Int J Cancer, 130(7), 1614-9 (2012)
146. O V Reshetnikov, T G Openko, G I Simonova, S A Kurilovich, S K Maliushina, I Ragino Iu and M I Voevoda: [Risk of gastric cancer dependent on serological markers of atrophic gastritis: cohort study]. Vopr Onkol, 58(5), 644-8 (2012)
147. M Yoshihara, T Hiyama, S Yoshida, M Ito, S Tanaka, Y Watanabe and K Haruma: Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: a case-control study. Scand J Gastroenterol, 42(6), 760-4 (2007)
148. R Lomba-Viana, M Dinis-Ribeiro, F Fonseca, A S Vieira, M J Bento and H Lomba-Viana: Serum pepsinogen test for early detection of gastric cancer in a European country. Eur J Gastroenterol Hepatol, 24(1), 37-41 (2012)
149. H Brenner, D Rothenbacher and M N Weck: Epidemiologic findings on serologically defined chronic atrophic gastritis strongly depend on the choice of the cutoff-value. Int J Cancer, 121(12), 2782-6 (2007)
150. K Miki and M Fujishiro: Cautious comparison between East and West is necessary in terms of the serum pepsinogen test. Dig Endosc, 21(2), 134-5 (2009)
151. P Malfertheiner, F Megraud, C A O'Morain, J Atherton, A T Axon, F Bazzoli, G F Gensini, J P Gisbert, D Y Graham, T Rokkas, E M El-Omar and E J Kuipers: Management of Helicobacter pylori infection - the Maastricht IV/ Florence Consensus Report. Gut, 61(5), 646-64 (2012)
152. O Tureci, U Sahin and M Pfreundschuh: Serological analysis of human tumor antigens: molecular definition and implications. Mol Med Today, 3(8), 342-9 (1997)
153. K D Preuss, C Zwick, C Bormann, F Neumann and M Pfreundschuh: Analysis of the B-cell repertoire against antigens expressed by human neoplasms. Immunol Rev, 188, 43-50 (2002)
154. L Dai, N Lei, M Liu and J Y Zhang: Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC). Exp Hematol Oncol, 2(1), 15 (2013)
155. P Zayakin, G Ancans, K Silina, I Meistere, Z Kalnina, D Andrejeva, E Endzelins, L Ivanova, A Pismennaja, A Ruskule, S Donina, T Wex, P Malfertheiner, M Leja and A Line: Tumor-associated autoantibody signature for the early detection of gastric cancer. Int J Cancer, 132(1), 137-47 (2013)
156. L A Liotta, J Kleinerman and G M Saidel: Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res, 34(5), 997-1004 (1974)
157. S J Kim, A Masago, Y Tamaki, K Akazawa, F Tsukamoto, J Sato, T Ozawa, Y Tsujino and S Noguchi: A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients. Breast Cancer Res Treat, 128(3), 765-73 (2011)
158. M G Krebs, R Sloane, L Priest, L Lancashire, J M Hou, A Greystoke, T H Ward, R Ferraldeschi, A Hughes, G Clack, M Ranson, C Dive and F H Blackhall: Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J Clin Oncol, 29(12), 1556-63 (2011)
159. H Ito, H Inoue, N Sando, S Kimura, K Gohda, J Sato, K Murakami, S Ito, N Odaka, H Satodate and S E Kudo: Prognostic impact of detecting viable circulating tumour cells in gastric cancer patients using a telomerase-specific viral agent: a prospective study. BMC Cancer, 12(1), 346 (2012)
160. K Hiraiwa, H Takeuchi, H Hasegawa, Y Saikawa, K Suda, T Ando, K Kumagai, T Irino, T Yoshikawa, S Matsuda, M Kitajima and Y Kitagawa: Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers. Ann Surg Oncol, 15(11), 3092-100 (2008)
161. L Cui, Y Lou, X Zhang, H Zhou, H Deng, H Song, X Yu, B Xiao, W Wang and J Guo: Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using piRNAs as markers. Clin Biochem, 44(13), 1050-7 (2011)
162. H Zhou, J M Guo, Y R Lou, X J Zhang, F D Zhong, Z Jiang, J Cheng and B X Xiao: Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J Mol Med (Berl), 88(7), 709-17 (2010)
163. S Jahr, H Hentze, S Englisch, D Hardt, F O Fackelmayer, R D Hesch and R Knippers: DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res, 61(4), 1659-65 (2001)
164. F Diehl, K Schmidt, M A Choti, K Romans, S Goodman, M Li, K Thornton, N Agrawal, L Sokoll, S A Szabo, K W Kinzler, B Vogelstein and L A Diaz: Circulating mutant DNA to assess tumor dynamics. Nat Med, 14(9), 985-90 (2008)
165. T Forshew, M Murtaza, C Parkinson, D Gale, D W Tsui, F Kaper, S J Dawson, A M Piskorz, M Jimenez-Linan, D Bentley, J Hadfield, A P May, C Caldas, J D Brenton and N Rosenfeld: Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci Transl Med, 4(136), 136ra68 (2012)
166. S J Dawson, D W Tsui, M Murtaza, H Biggs, O M Rueda, S F Chin, M J Dunning, D Gale, T Forshew, B Mahler-Araujo, S Rajan, S Humphray, J Becq, D Halsall, M Wallis, D Bentley, C Caldas and N Rosenfeld: Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med, 368(13), 1199-209 (2013)
167. K Hibi, T Goto, A Shirahata, M Saito, G Kigawa, H Nemoto and Y Sanada: Detection of TFPI2 methylation in the serum of gastric cancer patients. Anticancer Res, 31(11), 3835-8 (2011)
168. C Sakakura, T Hamada, K Miyagawa, M Nishio, A Miyashita, H Nagata, H Ida, S Yazumi, E Otsuji, T Chiba, K Ito and Y Ito: Quantitative analysis of tumor-derived methylated RUNX3 sequences in the serum of gastric cancer patients. Anticancer Res, 29(7), 2619-25 (2009)
169. M Hakim, Y Y Broza, O Barash, N Peled, M Phillips, A Amann and H Haick: Volatile organic compounds of lung cancer and possible biochmical pathways. Chem. Rev., 112, 5949-5966 (2012)
170. U Tisch, S Billan, M Ilouze, M Phillips, N Peled and H Haick: Volatile organic compounds in exhaled breath as biomarkers for the early detection and screening of lung cancer CML-Lung Cancer, 5, 107-117 (2012)
171. J D Pleil, M A Stiegel and T H Risby: Clinical breath analysis: discriminating between human endogenous compounds and exogenous (environmental) chemical confounders. J Breath Res, 7(1), 017107 (2013)
172. S Peng, M Hakim, Y Broza, S Billan, R Abdah-Brotnyak, A Kuten, U Tisch and H Haick: Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br J Cancer, 103, 542-551 (2010)
173. D F Altomare, M Di Lena, F Porcelli, L Trizio, E Travaglio, M Tutino, S Dragonieri, V Memeo and G de Gennaro: Exhaled volatile organic compounds identify patients with colorectal cancer. Br J Surg, 100(1), 144-50 (2013)
174. H Amal, L Ding, B B Liu, U Tisch, Z Q Xu, D Y Shi, Y Zhao, J Chen, R X Sun, H Liu, S L Ye, Z Y Tang and H Haick: The scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs). Int J Nanomedicine, 7, 4135-46 (2012)
175. Z Q Xu, Y Y Broza, R Ionsecu, U Tisch, L Ding, H Liu, Q Song, Y Y Pan, F X Xiong, K S Gu, G P Sun, Z D Chen, M Leja and H Haick: A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditions. Br J Cancer, 108(4), 941-50 (2013)
176. Z Q Xu, Y Y Broza, R Ionsecu, U Tisch, L Ding, H Liu, Q Song, Y Y Pan, F X Xiong, K S Gu, G P Sun, Z D Chen, M Leja and H Haick: A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditions. Br. J. Cancer, 108, 941-50 (2013)
177. V Ambros: The functions of animal microRNAs. Nature, 431(7006), 350-5 (2004)
178. G A Calin and C M Croce: MicroRNA signatures in human cancers. Nat Rev Cancer, 6(11), 857-66 (2006)
179. W Filipowicz, S N Bhattacharyya and N Sonenberg: Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet, 9(2), 102-14 (2008)
180. J Liu, M A Carmell, F V Rivas, C G Marsden, J M Thomson, J J Song, S M Hammond, L Joshua-Tor and G J Hannon: Argonaute2 is the catalytic engine of mammalian RNAi. Science, 305(5689), 1437-41 (2004)
181. A Goel and C R Boland: Epigenetics of colorectal cancer. Gastroenterology, 143(6), 1442-1460 e1 (2012)
182. A Link, J Kupcinskas, T Wex and P Malfertheiner: Macro-role of microRNA in gastric cancer. Dig Dis 30(3), 255-267 (2012)
183. J H Song and S J Meltzer: MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers. Gastroenterology, 143(1), 35-47 (2012)
184. J Lu, G Getz, E A Miska, E Alvarez-Saavedra, J Lamb, D Peck, A Sweet-Cordero, B L Ebert, R H Mak, A A Ferrando, J R Downing, T Jacks, H R Horvitz and T R Golub: MicroRNA expression profiles classify human cancers. Nature, 435(7043), 834-838 (2005)
185. T Ueda, S Volinia, H Okumura, M Shimizu, C Taccioli, S Rossi, H Alder, C G Liu, N Oue, W Yasui, K Yoshida, H Sasaki, S Nomura, Y Seto, M Kaminishi, G A Calin and C M Croce: Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol, 11(2), 136-146 (2010)
186. K Matsushima, H Isomoto, N Inoue, T Nakayama, T Hayashi, M Nakayama, K Nakao, T Hirayama and S Kohno: MicroRNA signatures in Helicobacter pylori-infected gastric mucosa. Int J Cancer, 128(2), 361-70 (2011)
187. F Petrocca, R Visone, M R Onelli, M H Shah, M S Nicoloso, I de Martino, D Iliopoulos, E Pilozzi, C G Liu, M Negrini, L Cavazzini, S Volinia, H Alder, L P Ruco, G Baldassarre, C M Croce and A Vecchione: E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell, 13(3), 272-86 (2008)
188. X Chen, Y Ba, L Ma, X Cai, Y Yin, K Wang, J Guo, Y Zhang, J Chen, X Guo, Q Li, X Li, W Wang, J Wang, X Jiang, Y Xiang, C Xu, P Zheng, J Zhang, R Li, H Zhang, X Shang, T Gong, G Ning, K Zen and C Y Zhang: Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res, 18(10), 997-1006 (2008)
189. P S Mitchell, R K Parkin, E M Kroh, B R Fritz, S K Wyman, E L Pogosova-Agadjanyan, A Peterson, J Noteboom, K C O'Briant, A Allen, D W Lin, N Urban, C W Drescher, B S Knudsen, D L Stirewalt, R Gentleman, R L Vessella, P S Nelson, D B Martin and M Tewari: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A, 105(30), 10513-8 (2008)
190. L Cui, X Zhang, G Ye, T Zheng, H Song, H Deng, B Xiao, T Xia, X Yu, Y Le and J Guo: Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer. Cancer, 119(9), 1618-26 (2013)
191. X Zhang, L Cui, G Ye, T Zheng, H Song, T Xia, X Yu, B Xiao, Y Le and J Guo: Gastric juice microRNA-421 is a new biomarker for screening gastric cancer. Tumour Biol, 33(6), 2349-55 (2012)
192. A Link, F Balaguer, Y Shen, T Nagasaka, J J Lozano, C R Boland and A Goel: Fecal MicroRNAs as novel biomarkers for colon cancer screening. Cancer Epidemiol Biomarkers Prev, 19(7), 1766-74 (2010)
193. A Link, V Becker, A Goel, T Wex and P Malfertheiner: Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer. PLoS One, 7(8), e42933 (2012)
194. L Xing, N W Todd, L Yu, H Fang and F Jiang: Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers. Mod Pathol, 23(8), 1157-64 (2010)
195. J A Weber, D H Baxter, S Zhang, D Y Huang, K H Huang, M J Lee, D J Galas and K Wang: The microRNA spectrum in 12 body fluids. Clin Chem, 56(11), 1733-41 (2010)
196. M P Hunter, N Ismail, X Zhang, B D Aguda, E J Lee, L Yu, T Xiao, J Schafer, M L Lee, T D Schmittgen, S P Nana-Sinkam, D Jarjoura and C B Marsh: Detection of microRNA expression in human peripheral blood microvesicles. PLoS One, 3(11), e3694 (2008)
197. L Pigati, S C Yaddanapudi, R Iyengar, D J Kim, S A Hearn, D Danforth, M L Hastings and D M Duelli: Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS One, 5(10), e13515 (2010)
198. J D Arroyo, J R Chevillet, E M Kroh, I K Ruf, C C Pritchard, D F Gibson, P S Mitchell, C F Bennett, E L Pogosova-Agadjanyan, D L Stirewalt, J F Tait and M Tewari: Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A, 108(12), 5003-8 (2011)
199. B S Li, Y L Zhao, G Guo, W Li, E D Zhu, X Luo, X H Mao, Q M Zou, P W Yu, Q F Zuo, N Li, B Tang, K Y Liu and B Xiao: Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PLoS One, 7(7), e41629 (2012)
200. R Liu, C Zhang, Z Hu, G Li, C Wang, C Yang, D Huang, X Chen, H Zhang, R Zhuang, T Deng, H Liu, J Yin, S Wang, K Zen, Y Ba and C Y Zhang: A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer, 47(5), 784-91 (2011)
201. M Tsujiura, D Ichikawa, S Komatsu, A Shiozaki, H Takeshita, T Kosuga, H Konishi, R Morimura, K Deguchi, H Fujiwara, K Okamoto and E Otsuji: Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer, 102(7), 1174-9 (2010)
202. X Yu, L Luo, Y Wu, Y Liu, X Zhao, X Zhang, L Cui, G Ye, Y Le and J Guo: Gastric juice miR-129 as a potential biomarker for screening gastric cancer. Med Oncol, 30(1), 365 (2013)
203. R Kogo, K Mimori, F Tanaka, S Komune and M Mori: Clinical significance of miR-146a in gastric cancer cases. Clin Cancer Res, 17(13), 4277-84 (2011)
204. M Okubo, T Tahara, T Shibata, H Yamashita, M Nakamura, D Yoshioka, J Yonemura, T Ishizuka, T Arisawa and I Hirata: Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population. Helicobacter, 15(6), 524-531 (2010)
205. M Y Song, H J Su, L Zhang, J L Ma, J Y Li, K F Pan and W C You: Genetic Polymorphisms of miR-146a and miR-27a, H. pylori Infection, and Risk of Gastric Lesions in a Chinese Population. PLoS One, 8(4), e61250 (2013)
206. T Ando, T Yoshida, S Enomoto, K Asada, M Tatematsu, M Ichinose, T Sugiyama and T Ushijima: DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Int J Cancer, 124(10), 2367-74 (2009)
207. Q Chen, X Chen, M Zhang, Q Fan, S Luo and X Cao: miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42. Dig Dis Sci, 56(7), 2009-16 (2011)
208. K W Tsai, C W Wu, L Y Hu, S C Li, Y L Liao, C H Lai, H W Kao, W L Fang, K H Huang, W C Chan and W C Lin: Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer. Int J Cancer, 129(11), 2600-10 (2011)
209. Z Chen, R Saad, P Jia, D Peng, S Zhu, M K Washington, Z Zhao, Z Xu and W El-Rifai: Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma. Cancer, 119(11), 1985-93 (2013)
210. C O Gigek, E S Chen, D Q Calcagno, F Wisnieski, R R Burbano and M A Smith: Epigenetic mechanisms in gastric cancer. Epigenomics, 4(3), 279-94 (2012)
211. P A Jones and S B Baylin: The fundamental role of epigenetic events in cancer. Nat Rev Genet, 3(6), 415-28 (2002)
212. F Y Huang, A O Chan, A Rashid, D K Wong, C H Cho and M F Yuen: Helicobacter pylori induces promoter methylation of E-cadherin via interleukin-1beta activation of nitric oxide production in gastric cancer cells. Cancer, 118(20), 4969-4980 (2012)
213. A S Cheng, M S Li, W Kang, V Y Cheng, J L Chou, S S Lau, M Y Go, C C Lee, T K Ling, E K Ng, J Yu, T H Huang, K F To, M W Chan, J J Sung and F K Chan: Helicobacter pylori Causes Epigenetic Dysregulation of FOXD3 to Promote Gastric Carcinogenesis. Gastroenterology 144(1), 122-33 (2013)
214. X X Lu, J L Yu, L S Ying, J Han, S Wang, Q M Yu, X B Wang, X H Fang and Z Q Ling: Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression. Cancer, 118(22), 5507-17 (2012)
215. A Ivanauskas, J Hoffmann, L V Jonaitis, R Markelis, E Juozaityte, L Kupcinskas, C Lofton-Day, C Rocken and P Malfertheiner: Distinct TPEF/HPP1 gene methylation patterns in gastric cancer indicate a field effect in gastric carcinogenesis. Dig Liver Dis 40(12), 920-926 (2008)
216. D Q Calcagno, C O Gigek, E S Chen, R R Burbano and A Smith: DNA and histone methylation in gastric carcinogenesis. World J Gastroenterol, 19(8), 1182-92 (2013)
217. X T Hu and C He: Recent progress in the study of methylated tumor suppressor genes in gastric cancer. Chin J Cancer, 32(1), 31-41 (2013)
218. N S Sapari, M Loh, A Vaithilingam and R Soong: Clinical potential of DNA methylation in gastric cancer: a meta-analysis. PLoS One, 7(4), e36275 (2012)
219. M Fukayama: Epstein-Barr virus and gastric carcinoma. Pathol Int, 60(5), 337-50 (2010)
220. T Niwa and T Ushijima: Induction of epigenetic alterations by chronic inflammation and its significance on carcinogenesis. Adv Genet, 71, 41-56 (2010)
221. X P Zou, B Zhang, X Q Zhang, M Chen, J Cao and W J Liu: Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Hum Pathol, 40(11), 1534-42 (2009)
222. F M Selaru, S David, S J Meltzer and J P Hamilton: Epigenetic events in gastrointestinal cancer. Am J Gastroenterol, 104(8), 1910-2 (2009)
223. K Balassiano, S Lima, M Jenab, K Overvad, A Tjonneland, M C Boutron-Ruault, F Clavel-Chapelon, F Canzian, R Kaaks, H Boeing, K Meidtner, A Trichopoulou, P Laglou, P Vineis, S Panico, D Palli, S Grioni, R Tumino, E Lund, H B Bueno-de-Mesquita, M E Numans, P H Peeters, Q J Ramon, M J Sanchez, C Navarro, E Ardanaz, M Dorronsoro, G Hallmans, R Stenling, R Ehrnstrom, S Regner, N E Allen, R C Travis, K T Khaw, G J Offerhaus, N Sala, E Riboli, P Hainaut, J Y Scoazec, B S Sylla, C A Gonzalez and Z Herceg: Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Cancer Lett, 311(1), 85-95 (2011)
224. Y Shigematsu, T Niwa, S Yamashita, H Taniguchi, R Kushima, H Katai, S Ito, T Tsukamoto, M Ichinose and T Ushijima: Identification of a DNA methylation marker that detects the presence of lymph node metastases of gastric cancers. Oncol Lett, 4(2), 268-274 (2012)
225. D Compare, A Rocco, E Liguori, F P D'Armiento, G Persico, S Masone, E Coppola-Bottazzi, R Suriani, M Romano and G Nardone: Global DNA hypomethylation is an early event in Helicobacter pylori-related gastric carcinogenesis. J Clin Pathol, 64(8), 677-82 (2011)
226. Z Zheng, A F Andersson, W Ye, O Nyren, S Normark and L Engstrand: A method for metagenomics of Helicobacter pylori from archived formalin-fixed gastric biopsies permitting longitudinal studies of carcinogenic risk. PLoS One, 6(10), e26442 (2011)
227. O Fletcher and R S Houlston: Architecture of inherited susceptibility to common cancer. Nat Rev Cancer, 10(5), 353-61 (2010) doi:10.1038/nrc2840
228. A Hishida, K Matsuo, Y Goto and N Hamajima: Genetic predisposition to Helicobacter pylori-induced gastric precancerous conditions. World Journal of Gastrointestinal Oncology, 2(10), 369 (2010)
229. P Guilford, B Humar and V Blair: Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice. Gastric Cancer, 13(1), 1-10 (2010)
230. L Fuccio, R M Zagari, L H Eusebi, L Laterza, V Cennamo, L Ceroni, D Grilli and F Bazzoli: Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med, 151(2), 121-128 (2009)
231. T Watanabe, M Tada, H Nagai, S Sasaki and M Nakao: Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology, 115(3), 642-648 (1998)
232. E M El-Omar, M Carrington, W H Chow, K E McColl, J H Bream, H A Young, J Herrera, J Lissowska, C C Yuan, N Rothman, G Lanyon, M Martin, J F Fraumeni and C S Rabkin: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature, 404(6776), 398-402 (2000)
233. A Hishida, K Matsuo, Y Goto, M Naito, K Wakai, K Tajima and N Hamajima: No associations of Toll-like receptor 2 (TLR2) -196 to -174del polymorphism with the risk of Helicobacter pylori seropositivity, gastric atrophy, and gastric cancer in Japanese. Gastric Cancer, 13(4), 251-7 (2010)
234. J Kupcinskas, T Wex, J Bornschein, M Selgrad, M Leja, E Juozaityte, G Kiudelis, L Jonaitis and P Malfertheiner: Lack of association between gene polymorphisms of Angiotensin converting enzyme, Nod-like receptor 1, Toll-like receptor 4, FAS/FASL and the presence of Helicobacter pylori-induced premalignant gastric lesions and gastric cancer in Caucasians. BMC Med Genet, 12, 112 (2011)
235. L Kupcinskas, T Wex, J Kupcinskas, M Leja, A Ivanauskas, L V Jonaitis, D Janciauskas, G Kiudelis, K Funka, A Sudraba, H M Chiu, J T Lin and P Malfertheiner: Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms are not associated with premalignant gastric conditions: a combined haplotype analysis. Eur J Gastroenterol Hepatol, 22(10), 1189-1195 (2010)
236. T Wex, A Leodolter, J Bornschein, D Kuester, T Kahne, S Kropf, C Albrecht, M Naumann, A Roessner and P Malfertheiner: Interleukin 1 beta (IL1B) gene polymorphisms are not associated with gastric carcinogenesis in Germany. Anticancer Res, 30(2), 505-11 (2010)
237. E M El Omar, M Carrington, W H Chow, K E L McColl, J H Bream, H A Young, J Herrera, J Lissowska, C C Yuan and N Rothman: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature, 404, 398-402 (2000)
238. T Tahara, T Shibata, H Yamashita, D Yoshioka, M Okubo, J Yonemura, Y Kamiya, T Ishizuka, Y Nakagawa, M Nagasaka, M Iwata, M Nakamura, I Hirata and T Arisawa: Synergistic effect of IL-1beta and TNF-alpha polymorphisms on the H. pylori-related gastric pre-malignant condition. Hepatogastroenterology, 59(120), 2416-20 (2012)
239. C A Yang, C Scheibenbogen, S Bauer, C Kleinle, T Wex, J Bornschein, P Malfertheiner, S Hellmig, R R Schumann and L Hamann: A frequent Toll-like receptor 1 gene polymorphism affects NK- and T-cell IFN-gamma production and is associated with Helicobacter pylori-induced gastric disease. Helicobacter, 18(1), 13-21 (2013)
240. M C Camargo, R Mera, P Correa, R M Peek, E T Fontham, K J Goodman, M B Piazuelo, L Sicinschi, J Zabaleta and B G Schneider: Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 15(9), 1674-87 (2006)
241. F Kamangar, C Cheng, C C Abnet and C S Rabkin: Interleukin-1B polymorphisms and gastric cancer riskâí"a meta-analysis. Cancer Epidemiology Biomarkers & Prevention, 15(10), 1920-1928 (2006)
242. B Peleteiro, N Lunet, C Carrilho, C Duraes, J C Machado, C La Vecchia and H Barros: Association between cytokine gene polymorphisms and gastric precancerous lesions: systematic review and meta-analysis. Cancer Epidemiology Biomarkers & Prevention, 19(3), 762-776 (2010)
243. B Vincenzi, G Patti, S Galluzzo, F Pantano, O Venditti, D Santini, A Ruzzo, G Schiavon, M Caraglia, M Marra, F Graziano and G Tonini: Interleukin 1beta-511T gene (IL1beta) polymorphism is correlated with gastric cancer in the Caucasian population: results from a meta-analysis. Oncol Rep, 20(5), 1213-20 (2008)
244. N Saeki, H Ono, H Sakamoto and T Yoshida: Genetic factors related to gastric cancer susceptibility identified using a genome-wide association study. Cancer Sci, 104(1), 1-8 (2013)
245. Y Shi, Z Hu, C Wu, J Dai, H Li, J Dong, M Wang, X Miao, Y Zhou, F Lu, H Zhang, L Hu, Y Jiang, Z Li, M Chu, H Ma, J Chen, G Jin, W Tan, T Wu, Z Zhang, D Lin and H Shen: A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1. Nat Genet, 43(12), 1215-8 (2011)
246. P Lochhead, B Frank, G L Hold, C S Rabkin, M T Ng, T L Vaughan, H A Risch, M D Gammon, J Lissowska, M N Weck, E Raum, H Muller, T Illig, N Klopp, A Dawson, K E McColl, H Brenner, W H Chow and E M El-Omar: Genetic variation in the prostate stem cell antigen gene and upper gastrointestinal cancer in white individuals. Gastroenterology, 140(2), 435-41 (2011)
247. J Bornschein, A Kandulski, M Selgrad and P Malfertheiner: From gastric inflammation to gastric cancer. Dig Dis, 28(4-5), 609-14 (2010)
248. E Segal, N Friedman, N Kaminski, A Regev and D Koller: From signatures to models: understanding cancer using microarrays. Nat Genet, 37 Suppl, S38-45 (2005)
249. E Segal, M Shapira, A Regev, D Pe'er, D Botstein, D Koller and N Friedman: Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data. Nat Genet, 34(2), 166-76 (2003)
250. K Garber: Genomic medicine. Gene expression tests foretell breast cancer's future. Science, 303(5665), 1754-5 (2004)
251. I Drozdov, C A Ouzounis, A M Shah and S Tsoka: Functional Genomics Assistant (FUGA): a toolbox for the analysis of complex biological networks. BMC Res Notes, 4(1), 462 (2011)
252. V K Mootha, C M Lindgren, K F Eriksson, A Subramanian, S Sihag, J Lehar, P Puigserver, E Carlsson, M Ridderstrale, E Laurila, N Houstis, M J Daly, N Patterson, J P Mesirov, T R Golub, P Tamayo, B Spiegelman, E S Lander, J N Hirschhorn, D Altshuler and L C Groop: PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet, 34(3), 267-73 (2003)
253. M Ronen, R Rosenberg, B I Shraiman and U Alon: Assigning numbers to the arrows: parameterizing a gene regulation network by using accurate expression kinetics. Proc Natl Acad Sci U S A, 99(16), 10555-60 (2002)
254. I Drozdov, S Tsoka, C A Ouzounis and A M Shah: Genome-wide expression patterns in physiological cardiac hypertrophy. BMC Genomics, 11, 557 (2010)
255. R Guimera and L A Nunes Amaral: Functional cartography of complex metabolic networks. Nature, 433(7028), 895-900 (2005)
256. S M Kim, S H Leem, I S Chu, Y Y Park, S C Kim, S B Kim, E S Park, J Y Lim, J Heo, Y J Kim, D G Kim, A Kaseb, Y N Park, X W Wang, S S Thorgeirsson and J S Lee: 65-gene-based risk score classifier predicts overall survival in hepatocellular carcinoma. Hepatology, 55(5), 1443-52 (2012)
257. I Drozdov, M Kidd, B Nadler, R L Camp, S M Mane, O Hauso, B I Gustafsson and I M Modlin: Predicting neuroendocrine tumor (carcinoid) neoplasia using gene expression profiling and supervised machine learning. Cancer, 115(8), 1638-50 (2009)
258. I Drozdov, B Svejda, B I Gustafsson, S Mane, R Pfragner, M Kidd and I M Modlin: Gene network inference and biochemical assessment delineates GPCR pathways and CREB targets in small intestinal neuroendocrine neoplasia. PLoS One, 6(8), e22457 (2011)
259. I M Modlin, B I Gustafsson, I Drozdov, B Nadler, R Pfragner and M Kidd: Principal component analysis, hierarchical clustering, and decision tree assessment of plasma mRNA and hormone levels as an early detection strategy for small intestinal neuroendocrine (carcinoid) tumors. Ann Surg Oncol, 16(2), 487-98 (2009)
260. A J Enright, S Van Dongen and C A Ouzounis: An efficient algorithm for large-scale detection of protein families. Nucleic Acids Res, 30(7), 1575-84 (2002)
261. E Birney, T D Andrews, P Bevan, M Caccamo, Y Chen, L Clarke, G Coates, J Cuff, V Curwen, T Cutts, T Down, E Eyras, X M Fernandez-Suarez, P Gane, B Gibbins, J Gilbert, M Hammond, H R Hotz, V Iyer, K Jekosch, A Kahari, A Kasprzyk, D Keefe, S Keenan, H Lehvaslaiho, G McVicker, C Melsopp, P Meidl, E Mongin, R Pettett, S Potter, G Proctor, M Rae, S Searle, G Slater, D Smedley, J Smith, W Spooner, A Stabenau, J Stalker, R Storey, A Ureta-Vidal, K C Woodwark, G Cameron, R Durbin, A Cox, T Hubbard and M Clamp: An overview of Ensembl. Genome Res, 14(5), 925-8 (2004)
262. K Furuta, T Arao, K Sakai, H Kimura, T Nagai, D Tamura, K Aomatsu, K Kudo, H Kaneda, Y Fujita, K Matsumoto, Y Yamada, K Yanagihara, M Sekijima and K Nishio: Integrated analysis of whole genome exon array and array-comparative genomic hybridization in gastric and colorectal cancer cells. Cancer Sci, 103(2), 221-7 (2012)
263. Y Z Zhang, L H Zhang, Y Gao, C H Li, S Q Jia, N Liu, F Cheng, D Y Niu, W C Cho, J F Ji and C Q Zeng: Discovery and validation of prognostic markers in gastric cancer by genome-wide expression profiling. World J Gastroenterol, 17(13), 1710-7 (2011)
264. E Rossi, C Klersy, R Manca, O Zuffardi and E Solcia: Correlation between genomic alterations assessed by array comparative genomic hybridization, prognostically informative histologic subtype, stage, and patient survival in gastric cancer. Hum Pathol, 42(12), 1937-45 (2011)
265. L Cheng, P Wang, S Yang, Y Yang, Q Zhang, W Zhang, H Xiao and H Gao: Identification of genes with a correlation between copy number and expression in gastric cancer. BMC Med Genomics, 5, 14 (2012)
266. A Kuroda, Y Tsukamoto, L T Nguyen, T Noguchi, I Takeuchi, M Uchida, T Uchida, N Hijiya, C Nakada, T Okimoto, M Kodama, K Murakami, K Matsuura, M Seto, H Ito, T Fujioka and M Moriyama: Genomic profiling of submucosal-invasive gastric cancer by array-based comparative genomic hybridization. PLoS One, 6(7), e22313 (2011)
267. N Deng, L K Goh, H Wang, K Das, J Tao, I B Tan, S Zhang, M Lee, J Wu, K H Lim, Z Lei, G Goh, Q Y Lim, A L Tan, D Y Sin Poh, S Riahi, S Bell, M M Shi, R Linnartz, F Zhu, K G Yeoh, H C Toh, W P Yong, H C Cheong, S Y Rha, A Boussioutas, H Grabsch, S Rozen and P Tan: A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets. Gut, 61(5), 673-84 (2012)
268. A M Dulak, S E Schumacher, J van Lieshout, Y Imamura, C Fox, B Shim, A H Ramos, G Saksena, S C Baca, J Baselga, J Tabernero, J Barretina, P C Enzinger, G Corso, F Roviello, L Lin, S Bandla, J D Luketich, A Pennathur, M Meyerson, S Ogino, R A Shivdasani, D G Beer, T E Godfrey, R Beroukhim and A J Bass: Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer Res, 72(17), 4383-93 (2012)
269. Y Zhang, S Wang, D Li, J Zhnag, D Gu, Y Zhu and F He: A systems biology-based classifier for hepatocellular carcinoma diagnosis. PLoS One, 6(7), e22426 (2011)
270. J Saez-Rodriguez, L G Alexopoulos, M Zhang, M K Morris, D A Lauffenburger and P K Sorger: Comparing signaling networks between normal and transformed hepatocytes using discrete logical models. Cancer Res, 71(16), 5400-11 (2011)
271. X Y Goh, J R Rees, A L Paterson, S F Chin, J C Marioni, V Save, M O'Donovan, P P Eijk, D Alderson, B Ylstra, C Caldas and R C Fitzgerald: Integrative analysis of array-comparative genomic hybridisation and matched gene expression profiling data reveals novel genes with prognostic significance in oesophageal adenocarcinoma. Gut, 60(10), 1317-26 (2011)
272. A Aggarwal, D L Guo, Y Hoshida, S T Yuen, K M Chu, S So, A Boussioutas, X Chen, D Bowtell, H Aburatani, S Y Leung and P Tan: Topological and functional discovery in a gene coexpression meta-network of gastric cancer. Cancer Res, 66(1), 232-41 (2006)
273. J Cui, F Li, G Wang, X Fang, J D Puett and Y Xu: Gene-expression signatures can distinguish gastric cancer grades and stages. PLoS One, 6(3), e17819 (2011)
274. J Y Cho, J Y Lim, J H Cheong, Y Y Park, S L Yoon, S M Kim, S B Kim, H Kim, S W Hong, Y N Park, S H Noh, E S Park, I S Chu, W K Hong, J A Ajani and J S Lee: Gene expression signature-based prognostic risk score in gastric cancer. Clin Cancer Res, 17(7), 1850-7 (2011)
275. S M Kim, Y Y Park, E S Park, J Y Cho, J G Izzo, D Zhang, S B Kim, J H Lee, M S Bhutani, S G Swisher, X Wu, K R Coombes, D Maru, K K Wang, N S Buttar, J A Ajani and J S Lee: Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome. PLoS One, 5(11), e15074 (2010)
276. C J Peters, J R Rees, R H Hardwick, J S Hardwick, S L Vowler, C A Ong, C Zhang, V Save, M O'Donovan, D Rassl, D Alderson, C Caldas and R C Fitzgerald: A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia. Gastroenterology, 139(6), 1995-2004 e15 (2010)
277. A Saadi, N B Shannon, P Lao-Sirieix, M O'Donovan, E Walker, N J Clemons, J S Hardwick, C Zhang, M Das, V Save, M Novelli, F Balkwill and R C Fitzgerald: Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers. Proc Natl Acad Sci U S A, 107(5), 2177-82 (2010)
278. C H Ooi, T Ivanova, J Wu, M Lee, I B Tan, J Tao, L Ward, J H Koo, V Gopalakrishnan, Y Zhu, L L Cheng, J Lee, S Y Rha, H C Chung, K Ganesan, J So, K C Soo, D Lim, W H Chan, W K Wong, D Bowtell, K G Yeoh, H Grabsch, A Boussioutas and P Tan: Oncogenic pathway combinations predict clinical prognosis in gastric cancer. PLoS Genet, 5(10), e1000676 (2009)
279. Y Y Wang, Z Y Ye, Z S Zhao, H Q Tao and S G Li: Systems biology approach to identification of biomarkers for metastatic progression in gastric cancer. J Cancer Res Clin Oncol, 136(1), 135-41 (2010)
280. M A Shah, R Khanin, L Tang, Y Y Janjigian, D S Klimstra, H Gerdes and D P Kelsen: Molecular classification of gastric cancer: a new paradigm. Clin Cancer Res, 17(9), 2693-701 (2011)
281. G Wang, N Hu, H H Yang, L Wang, H Su, C Wang, R Clifford, E M Dawsey, J M Li, T Ding, X Y Han, C Giffen, A M Goldstein, P R Taylor and M P Lee: Comparison of global gene expression of gastric cardia and noncardia cancers from a high-risk population in china. PLoS One, 8(5), e63826 (2013)
282. Z Lei, I B Tan, K Das, N Deng, H Zouridis, S Pattison, C Chua, Z Feng, Y K Guan, C H Ooi, T Ivanova, S Zhang, M Lee, J Wu, A Ngo, S Manesh, E Tan, B T Teh, J B Yan So, L K Goh, A Boussioutas, T K Hon Lim, H Flotow, P Tan and S G Rozen: Identification of Molecular Subtypes of Gastric Cancer with Different Responses to PI3-Kinase Inhibitors and 5-Fluorouracil. Gastroenterology (2013)
283. H Wong and T Yau: Molecular targeted therapies in advanced gastric cancer: does tumor histology matter? Therap Adv Gastroenterol, 6(1), 15-31 (2013)
284. D Wang, F Ye, Y Sun, W Li, H Liu, J Jiang, Y Zhang, C Liu, W Tong, L Gao, W Zhang, T Seetoe, P Lee, J Suo and D Y Zhang: Protein signatures for classification and prognosis of gastric cancer a signaling pathway-based approach. Am J Pathol, 179(4), 1657-66 (2011)
285. J Qian, F Li, J Yu, Z Yang and J Chen: Mining predictive biomarker for neoadjuvant chemotherapy in gastric cancer by proteomics. Hepatogastroenterology, 58(110-111), 1828-33 (2011)
286. D Torti, F Sassi, F Galimi, S Gastaldi, T Perera, P M Comoglio, L Trusolino and A Bertotti: A preclinical algorithm of soluble surrogate biomarkers that correlate with therapeutic inhibition of the MET oncogene in gastric tumors. Int J Cancer, 130(6), 1357-66 (2012)
287. S O Deininger, M P Ebert, A Futterer, M Gerhard and C Rocken: MALDI imaging combined with hierarchical clustering as a new tool for the interpretation of complex human cancers. J Proteome Res, 7(12), 5230-6 (2008)
288. S Meding, U Nitsche, B Balluff, M Elsner, S Rauser, C Schone, M Nipp, M Maak, M Feith, M P Ebert, H Friess, R Langer, H Hofler, H Zitzelsberger, R Rosenberg and A Walch: Tumor classification of six common cancer types based on proteomic profiling by MALDI imaging. J Proteome Res, 11(3), 1996-2003 (2012)
289. W Liu, B Liu, Q Cai, J Li, X Chen and Z Zhu: Proteomic identification of serum biomarkers for gastric cancer using multi-dimensional liquid chromatography and 2D differential gel electrophoresis. Clin Chim Acta, 413(13-14), 1098-106 (2012)
290. K M Fock, P Katelaris, K Sugano, T L Ang, R Hunt, N J Talley, S K Lam, S D Xiao, H J Tan, C Y Wu, H C Jung, B H Hoang, U Kachintorn, K L Goh, T Chiba and A A Rani: Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. Journal of gastroenterology and hepatology, 24(10), 1587-600 (2009)